---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-001050"
form_type: "8-K"
ticker: "SBC"
cik: "0001930313"
company_name: "SBC Medical Group Holdings Inc"
filed_at: "2025-03-28T23:59:59+00:00"
generated_at: "2026-05-24T03:24:06.157327+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SBC Medical Q4 revenue down 29% to $44M; FY 2024 net income up 18% to $47M

## Summary
- Q4 2024 revenue $44M (down 29% YoY); net income $7M (down 54% YoY); EPS $0.06 (down 58%).
- Full-year 2024 revenue $205M (up 6% YoY); net income $47M (up 18% YoY); EPS $0.48 (up 14%).
- Q4 EBITDA $21M (down 22% YoY) with margin 47%; full-year EBITDA $89M (up 8% YoY) with margin 43%.
- Partner clinics grew by 43 to 251 as of Dec 31, 2024, expanding the clinic network.
- Income from operations fell 80% in Q4 to $5M but was nearly flat for the full year at $70M.

## SEC filing metadata
- accession: 0001641172-25-001050
- form_type: 8-K
- ticker: SBC
- cik: 0001930313
- company_name: SBC Medical Group Holdings Inc
- filed_at: 2025-03-28T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1930313/000164117225001050/0001641172-25-001050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1930313/000164117225001050/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-001050
- JSON: https://secwatch.observer/filing/0001641172-25-001050.json
- Plain text: https://secwatch.observer/filing/0001641172-25-001050.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.